Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Brandl

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Transplantation Proceedings|April 6, 2005
Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion modelU Brandl, M Erhardt, H Joeckle, et al.
Transplantation Proceedings|May 2, 2006
Fluorescent microspheres reveal different regional blood flow in hyperacutely rejected nontransgenic and hDAF pig heartsU Brandl, M Erhardt, H Jöckle, et al.
Klinische Padiatrie|July 21, 2005
[Optimizing epilepsy therapy in children and adolescents with lamotrigine]H Siemes, U Brandl, C Helmstädter, et al.
Transplantation Proceedings|April 6, 2005
Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboonsP Brenner, M Schmoeckel, C Wimmer, et al.
Transplantation Proceedings|April 6, 2005
Combination of hDAF-transgenic pig hearts and immunoadsorption in heterotopic xenotransplantation of immunosuppressed baboonsP Brenner, M Schmoeckel, C Wimmer, et al.
Circulation|December 31, 1997
Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantationB R Jaeger, B Meiser, D Nagel, et al.
Transplantation Proceedings|March 17, 2007
Transgenic animals in experimental xenotransplantation models: orthotopic heart transplantation in the pig-to-baboon modelU Brandl, S Michel, M Erhardt, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Transplantation Proceedings|April 6, 2005
Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion modelU Brandl, M Erhardt, H Joeckle, et al.
Transplantation Proceedings|May 2, 2006
Fluorescent microspheres reveal different regional blood flow in hyperacutely rejected nontransgenic and hDAF pig heartsU Brandl, M Erhardt, H Jöckle, et al.
Klinische Padiatrie|July 21, 2005
[Optimizing epilepsy therapy in children and adolescents with lamotrigine]H Siemes, U Brandl, C Helmstädter, et al.
Transplantation Proceedings|April 6, 2005
Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboonsP Brenner, M Schmoeckel, C Wimmer, et al.
Transplantation Proceedings|April 6, 2005
Combination of hDAF-transgenic pig hearts and immunoadsorption in heterotopic xenotransplantation of immunosuppressed baboonsP Brenner, M Schmoeckel, C Wimmer, et al.
Circulation|December 31, 1997
Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantationB R Jaeger, B Meiser, D Nagel, et al.
Transplantation Proceedings|March 17, 2007
Transgenic animals in experimental xenotransplantation models: orthotopic heart transplantation in the pig-to-baboon modelU Brandl, S Michel, M Erhardt, et al.
Pageof 4